GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cabio Biotech (Wuhan) Co Ltd (SHSE:688089) » Definitions » Days Sales Outstanding

Cabio Biotech (Wuhan) Co (SHSE:688089) Days Sales Outstanding : 178.97 (As of Mar. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Cabio Biotech (Wuhan) Co Days Sales Outstanding?

Cabio Biotech (Wuhan) Co's average Accounts Receivable for the three months ended in Mar. 2024 was ¥229.5 Mil. Cabio Biotech (Wuhan) Co's Revenue for the three months ended in Mar. 2024 was ¥117.0 Mil. Hence, Cabio Biotech (Wuhan) Co's Days Sales Outstanding for the three months ended in Mar. 2024 was 178.97.

The historical rank and industry rank for Cabio Biotech (Wuhan) Co's Days Sales Outstanding or its related term are showing as below:

SHSE:688089' s Days Sales Outstanding Range Over the Past 10 Years
Min: 106.19   Med: 131.1   Max: 166.04
Current: 158.03

During the past 11 years, Cabio Biotech (Wuhan) Co's highest Days Sales Outstanding was 166.04. The lowest was 106.19. And the median was 131.10.

SHSE:688089's Days Sales Outstanding is ranked worse than
79.95% of 883 companies
in the Biotechnology industry
Industry Median: 72.66 vs SHSE:688089: 158.03

Cabio Biotech (Wuhan) Co's Days Sales Outstanding declined from Mar. 2023 (187.82) to Mar. 2024 (178.97).


Cabio Biotech (Wuhan) Co Days Sales Outstanding Historical Data

The historical data trend for Cabio Biotech (Wuhan) Co's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cabio Biotech (Wuhan) Co Days Sales Outstanding Chart

Cabio Biotech (Wuhan) Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Days Sales Outstanding
Get a 7-Day Free Trial Premium Member Only Premium Member Only 124.99 134.65 145.32 143.18 166.04

Cabio Biotech (Wuhan) Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 187.82 145.06 142.14 163.73 178.97

Competitive Comparison of Cabio Biotech (Wuhan) Co's Days Sales Outstanding

For the Biotechnology subindustry, Cabio Biotech (Wuhan) Co's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cabio Biotech (Wuhan) Co's Days Sales Outstanding Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cabio Biotech (Wuhan) Co's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Cabio Biotech (Wuhan) Co's Days Sales Outstanding falls into.



Cabio Biotech (Wuhan) Co Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Cabio Biotech (Wuhan) Co's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

Days Sales Outstanding (A: Dec. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2022 ) + Accounts Receivable (A: Dec. 2023 )) / count ) / Revenue (A: Dec. 2023 )*Days in Period
=( (188.967 + 214.813) / 2 ) / 443.803*365
=201.89 / 443.803*365
=166.04

Cabio Biotech (Wuhan) Co's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

Days Sales Outstanding (Q: Mar. 2024 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2023 ) + Accounts Receivable (A: Mar. 2024 )) / count ) / Revenue (A: Mar. 2024 )*Days in Period
=( (214.813 + 244.207) / 2 ) / 117.02*365 / 4
=229.51 / 117.02*365 / 4
=178.97

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cabio Biotech (Wuhan) Co  (SHSE:688089) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.


Cabio Biotech (Wuhan) Co Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Cabio Biotech (Wuhan) Co's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.


Cabio Biotech (Wuhan) Co (SHSE:688089) Business Description

Traded in Other Exchanges
N/A
Address
No. 999, Gaoxin Avenue, Donghu New Technology Development Zone, Wuhan, CHN, 430073
Cabio Biotech (Wuhan) Co Ltd is a biotechnology company, engaged in Research & Development, production and sales of polyunsaturated fatty acids ARA, algae oil DHA and SA, natural B-carotene and other series products. The products are used in infant formula, dietary nutrition supplements and health Food, special medical formula food and other fields. The company's product sales area covers China, the United States, Europe, Australia, New Zealand, South Korea, and Southeast Asia.
Executives
Shang Yun Core technical personnel
Wang Hua Biao Directors, senior managers
Geng An Feng senior management
Du Bin Director
Yi Hua Rong senior management
Ma Tao senior management
Li Xiang Yu senior management
Wu Yu Jun Supervisors
Xiao Min senior management
Wang Zhi Ming senior management
Lu Shu Huan Core technical personnel
Yi De Wei Director

Cabio Biotech (Wuhan) Co (SHSE:688089) Headlines

No Headlines